MAPT and early-onset autosomal dominant Alzheimer disease: In d-galactose/aluminum chloride (d-gal/AlCl3)-induced Alzheimer’s disease (AD)-like rat models, CA extracts significantly improved spatial memory performance and motor dysfunction by alleviating tau pathology and oxidative stress through the activation of the Akt/GSK3β pathway [43].